Insider Trading & Ownership - van Houte Hans

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for van Houte Hans
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-11-01
Sale
2024-11-01
5:57 pm
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
3,546$24.28$86,08333,724
(Direct)
View
2024-10-30
Sale
2024-10-30
8:30 pm
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
2,368$24.3$57,554101,201
(Direct)
View
2024-08-26
Sale
2024-08-26
5:41 pm
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
20,000$25.22$504,37031,002
(Direct)
View
2024-08-01
Sale
2024-08-01
7:06 pm
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
3,477$21.45$74,57651,002
(Direct)
View
2024-07-30
Sale
2024-07-30
7:06 pm
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
2,490$20.67$51,463127,046
(Direct)
View
2024-06-20
Sale
2024-06-20
4:58 pm
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
20,000$20.01$400,21648,333
(Direct)
View
2024-05-02
Sale
2024-05-02
6:01 pm
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
3,499$12.83$44,87868,333
(Direct)
View
2024-04-30
Sale
2024-04-30
6:33 pm
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
1,387$12.04$16,703108,035
(Direct)
View
2024-02-16
Sale
2024-02-16
7:20 pm
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
6,812$10.02$68,22368,333
(Direct)
View
2024-01-30
Sale
2024-01-30
6:53 pm
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
1,671$7.9902$13,352116,234
(Direct)
View
2023-12-20
Sale
2023-12-21
5:19 pm
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
3,541$10$35,42171,930
(Direct)
View
2023-12-19
Sale
2023-12-20
4:55 pm
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
10,906$10$109,09375,471
(Direct)
View
2023-10-31
Sale
2023-11-01
4:41 pm
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
1,080$5.1974$5,613132,352
(Direct)
View
2023-07-31
Sale
2023-08-01
4:28 pm
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
1,245$9.6547$12,020133,432
(Direct)
View
2023-05-01
Sale
2023-05-02
4:33 pm
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
721$9.8763$7,121110,677
(Direct)
View
2023-01-30
Sale
2023-02-01
4:17 pm
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
924$11.78$10,884111,398
(Direct)
View
2022-10-31
Sale
2022-11-01
7:35 pm
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
739$12.88$9,519112,322
(Direct)
View
2022-08-01
Sale
2022-08-02
5:46 pm
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
752$15.67$11,784113,061
(Direct)
View
2022-05-02
Sale
2022-05-03
7:03 pm
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
697$11.75$8,19045,480
(Direct)
View
2021-02-24
Sale
2021-02-25
4:18 pm
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
35,419$39.9$1,413,21865,667
(Direct)
View
2021-02-22
Sale
2021-02-23
6:04 pm
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
5,330$39.93$212,83997,753
(Direct)
View
2021-02-18
Sale
2021-02-22
4:09 pm
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
13,583$35.46$481,62169,750
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-10-30
Exercise
2024-10-30
8:30 pm
N/A
N/A
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
8,636$0101,201
(Direct)
View
2024-07-30
Exercise
2024-07-30
7:06 pm
N/A
N/A
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
8,636$0127,046
(Direct)
View
2024-04-30
Exercise
2024-04-30
6:33 pm
N/A
N/A
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
4,886$0108,035
(Direct)
View
2024-02-13
Option Award
2024-02-15
07:23 am
N/A
2034-02-12
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
195,000$0195,000
(Direct)
View
2024-01-30
Exercise
2024-01-30
6:53 pm
N/A
N/A
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
4,886$0116,234
(Direct)
View
2023-10-30
Exercise
2023-11-01
4:41 pm
N/A
N/A
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
4,886$0132,352
(Direct)
View
2023-07-30
Exercise
2023-08-01
4:28 pm
N/A
N/A
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
4,886$0133,432
(Direct)
View
2023-04-30
Exercise
2023-05-02
4:33 pm
N/A
N/A
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
2,886$0110,677
(Direct)
View
2023-02-14
Option Award
2023-02-15
4:13 pm
N/A
2033-02-13
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
112,900$0112,900
(Direct)
View
2023-01-30
Exercise
2023-02-01
4:17 pm
N/A
N/A
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
2,886$0111,398
(Direct)
View
2022-10-30
Exercise
2022-11-01
7:35 pm
N/A
N/A
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
2,886$0112,322
(Direct)
View
2022-08-09
Option Award
2022-08-10
4:17 pm
N/A
2032-08-08
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
120,000$0120,000
(Direct)
View
2022-07-30
Exercise
2022-08-02
5:46 pm
N/A
N/A
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
2,886$0113,061
(Direct)
View
2022-05-31
Exercise
2022-06-01
4:57 pm
N/A
N/A
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
68,333$0.8470,522
(Direct)
View
2022-05-31
Exercise
2022-06-01
4:57 pm
N/A
2026-04-26
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
68,333$070,522
(Direct)
View
2022-04-30
Exercise
2022-05-03
7:03 pm
N/A
N/A
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
2,886$045,480
(Direct)
View
2022-01-19
Option Award
2022-01-21
4:16 pm
N/A
2032-01-18
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
150,071$0150,071
(Direct)
View
2021-02-24
Exercise
2021-02-25
4:18 pm
N/A
2028-03-01
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
35,419$065,667
(Direct)
View
2021-02-24
Exercise
2021-02-25
4:18 pm
N/A
N/A
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
20,393$1.265,667
(Direct)
View
2021-02-24
Exercise
2021-02-25
4:18 pm
N/A
N/A
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
13,197$1.8665,667
(Direct)
View
2021-02-24
Exercise
2021-02-25
4:18 pm
N/A
N/A
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
1,829$7.2665,667
(Direct)
View
2021-02-22
Exercise
2021-02-23
6:04 pm
N/A
N/A
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
1,417$0.8497,753
(Direct)
View
2021-02-22
Exercise
2021-02-23
6:04 pm
N/A
2026-04-26
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
5,330$097,753
(Direct)
View
2021-02-22
Exercise
2021-02-23
6:04 pm
N/A
N/A
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
3,913$1.297,753
(Direct)
View
2021-02-18
Exercise
2021-02-22
4:09 pm
N/A
N/A
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
13,583$0.8469,750
(Direct)
View
2021-02-18
Exercise
2021-02-22
4:09 pm
N/A
2026-01-27
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
13,583$069,750
(Direct)
View
2021-02-11
Option Award
2021-02-12
7:27 pm
N/A
2031-02-10
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
40,000$040,000
(Direct)
View

Ownership
2020-07-23
6:46 pm
N/A
2028-03-01
Nurix Therapeutics Inc.NRIXvan Houte Hans
Chief Financial Officer
0$0271,665
(Direct)
View